Literature DB >> 17895504

Estrogen receptor alpha and beta gene polymorphisms are not risk factors for recurrent miscarriage in a Brazilian population.

Aline Morandi Aléssio1, Lúcia Helena Siqueira, Egle Cristina Couto de Carvalho, Ricardo Barini, Antônio de Pádua Mansur, Nelci Fenalti Hoehr, Joyce Maria Annichino-Bizzacchi.   

Abstract

The aim of this study was to determine the prevalence of alpha (ESR1: c.454-397T>C and c.454-351A>G) and beta (ESR2: 1082G>A and 1730G>A) estrogen receptor gene polymorphisms in 2 Brazilian ethnic groups (Caucasian, African Brazilian) and to investigate their association with recurrent miscarriage (RM) in 75 women with a history of 3 or more consecutive pregnancy losses and 139 controls with at least 2 live births and no history of pregnancy loss. Polymerase chain reaction and restriction fragment length polymorphism were used to identify gene polymorphisms. Coagulation methods were used to measure protein C, protein S, and fibrinogen, and a chromogenic method was used for antithrombin quantification. Significantly higher prevalences of 1082G>A and 1730G>A polymorphisms were seen in African Brazilian and Caucasian controls, respectively. There was no association between RM and ESR polymorphisms. There was a difference in the genotype prevalence in the c.454-39T>C polymorphism between RM and control Caucasians, but this finding was not associated with an increased risk of miscarriage. There was no synergistic or additive effect between ESR polymorphisms and thrombophilia in RM patients. A difference in the prevalence of ESR polymorphisms was observed, according to ethnic origin. ESR polymorphisms could not be considered a risk factor for RM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17895504     DOI: 10.1177/1076029607304093

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  7 in total

1.  The haplotypes GCA and ACA in ESR1 gene are associated with the susceptibility of recurrent spontaneous abortion (RSA) in Chinese Han: A case-control study and meta-analysis.

Authors:  Liang Tang; Qin Xiang; Ju Xiang; Jianming Li
Journal:  Medicine (Baltimore)       Date:  2022-05-27       Impact factor: 1.817

2.  Evaluation of in vitro fertilization parameters and estrogen receptor alpha gene polymorphisms for women with unexplained infertility.

Authors:  Ozge Uner Ayvaz; Abdullah Ekmekçi; Volkan Baltaci; Hacer Ilke Onen; Evrim Unsal
Journal:  J Assist Reprod Genet       Date:  2009-10-29       Impact factor: 3.412

3.  Polymorphisms in the Estrogen Receptor Beta Gene and the Risk of Unexplained Recurrent Spontaneous Abortion.

Authors:  Marzieh Mahdavipour; Saeed Zarei; Ramina Fatemi; Haleh Edalatkhah; Hamed Heidari-Vala; Mahmood Jeddi-Tehrani; Farah Idali
Journal:  Avicenna J Med Biotechnol       Date:  2017 Jul-Sep

4.  The AGT Haplotype of the ESR2 Gene Containing the Polymorphisms rs2077647A, rs4986938G, and rs1256049T Increases the Susceptibility of Unexplained Recurrent Spontaneous Abortion in Women in the Chinese Hui Population.

Authors:  Dawei Tang; Junhua Bao; Gang Bai; Miaomiao Hao; Rui Jin; Fang Liu
Journal:  Med Sci Monit       Date:  2020-05-02

5.  The role of estrogen receptor-beta gene +1730G/A polymorphisms in recurrent pregnancy loss: A protocol for systematic review and meta-analysis.

Authors:  Fangxiang Mu; Minge Shi; Li Huang; Dafen Wang; Aiqun Shen
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

6.  Investigation on estrogen receptor alpha gene polymorphisms in Iranian women with recurrent pregnancy loss.

Authors:  Marzieh Mahdavipour; Farah Idali; Saeed Zarei; Saeed Talebi; Ramina Fatemi; Mahmood Jeddi-Tehrani; Somayeh Pahlavan; Farzad Rajaei
Journal:  Iran J Reprod Med       Date:  2014-06

7.  Association of Estrogen Receptor 1 Genetic Polymorphisms with Recurrent Spontaneous Abortion Risk.

Authors:  Xun-Qiang Yin; Hong-Mei Ju; Qiang Guo; Lin Zhao; Xiao-Xiao Zhu; Ran Wei; Zhen Zhang; Yun-Hong Zhang; Bin Wang; Xia Li
Journal:  Chin Med J (Engl)       Date:  2018-08-05       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.